日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic Factors in High Grade Osteosarcoma Patients Who Received Neoadjuvant Therapy and Subsequently Underwent Surgery: Data from the Turkish Oncology Group

接受新辅助治疗后行手术治疗的高级别骨肉瘤患者的预后因素:来自土耳其肿瘤协作组的数据

Sever, Nadiye; Şimşek, Fatih; Onur, İlknur Deliktaş; Arvas, Hayati; Guliyev, Tural; Şakalar, Teoman; Çiçek, Ceren Mordağ; Orman, Seval; Çetin, Emine Bihter; Kayaş, Kamil; Akbaş, Sinem; Ağyol, Yeşim; Güren, Ali Kaan; Erel, Pınar; Kocaaslan, Erkam; Paçacı, Burak; Tunç, Mustafa Alperen; Çelebi, Abdussamet; Majidova, Nargiz; Durnalı, Ayşe; Şimşek, Melih; Şahbazlar, Mustafa; Işık, Selver; Arıkan, Rukiye; Ercelep, Özlem; Sarı, Murat; Köstek, Osman; Bayoğu, İbrahim Vedat

Prognostic implications of cancer-associated fibroblasts and desmoplastic reaction in stage III colon cancer risk groups.

癌症相关成纤维细胞和促纤维增生反应在 III 期结肠癌风险组中的预后意义。

Demircan Nazım Can, Tekin Mehmet Fatih, Akın Telli Tuğba, Arıkan Rukiye, Başoğlu Tuğba, Çelebi Abdussamet, Yaşar Alper, Işık Selver, Ercelep Özlem, Dane Faysal, Ataizi Çelikel Çiğdem, Yumuk Perran Fulden

Impact of renin angiotensin system inhibitors on survival of patients with metastatic non-small cell lung cancer

肾素-血管紧张素系统抑制剂对转移性非小细胞肺癌患者生存率的影响

Sever, Nadiye; Yunusov, Emil; Çelebi, Abdussamet; Yaşar, Alper; Majidova, Nargiz; Kocaaslan, Erkam; Erel, Pınar; Ağyol, Yeşim; Güren, Ali Kaan; Işık, Selver; Arıkan, Rukiye; Ercelep, Özlem; Köstek, Osman; Bayoğlu, İbrahim Vedat; Sarıc, Murat

Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study

哪些因素有助于决定转移性肾细胞癌患者对一线酪氨酸激酶抑制剂的长期疗效:一项土耳其多中心研究

Majidova, Nargiz; Seyyar, Mustafa; Bayraktar, Demet Işık; Dinç, Gülhan; İsgandarov, Elfag; Huseynov, Javid; Yaşar, Alper; Çelebi, Abdussamet; Sever, Nadiye; Kocaaslan, Erkam; Erel, Pınar; Ağyol, Yeşim; Güren, Ali Kaan; Arıkan, Rukiye; Işık, Selver; Ercelep, Özlem; Demirağ, Güzin; Kefeli, Umut; Köstek, Osman; Bayoğlu, İbrahim Vedat; Sarı, Murat

Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group

卡培他滨联合替莫唑胺方案治疗神经内分泌肿瘤的疗效:来自土耳其肿瘤协作组的数据

Ünal, Çağlar; Azizy, Abdulmunir; Karabulut, Senem; Taştekin, Didem; Akyıldız, Arif; Yaşar, Serkan; Yalçın, Şuayib; Çoban, Eyüp; Evrensel, Türkkan; Kalkan, Ziya; Oruç, Zeynep; Derin, Sümeyra; Turna, Zeynep Hande; Bayram, Doğan; Köş, Fahriye Tuğba; Şendur, Mehmet Ali Nihat; Sever, Nadiye; Ercelep, Özlem; Seyyar, Mustafa; Kefeli, Umut; Uygun, Kazım; Özçelik, Melike; Ön, Sercan; Şanlı, Ulus Ali; Canaslan, Kübra; Ünek, İlkay Tuba; Yücel, Kadriye Bir; Özdemir, Nuriye; Yazıcı, Ozan; Güzel, Halil Göksel; Salim, Derya Kıvrak; Göksu, Sema Sezgin; Tatlı, Ali Murat; Ordu, Çetin; Selvi, Oğuzhan; Sakin, Abdullah; Büyükbayram, Mehmet Emin; Dursun, Bengü; Ürün, Yüksel; Arak, Hacı; Ağdaş, Gözde; Uğraklı, Muzaffer; Hendem, Engin; Eryılmaz, Melek Karakurt; Bilgin, Burak; Topçu, Atakan; Şimşek, Melih; Büyükşimşek, Mahmut; Akay, Büşra; Erdal, Gülçin Şahingöz; Karataş, Fatih; Alan, Özkan; Çağlayan, Melek; Kahvecioğlu, Fatma Akdağ; Demirci, Ayşe; Paksoy, Nail; Çetin, Bülent; Gümüş, Mahmut; Ak, Naziye; Aydınalp, Yasemin; Paydaş, Semra; Güven, Deniz Can; Kılıçkap, Saadettin; Sağlam, Sezer

PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score

PNI 作为潜在的附加生物标志物,可改善 IMDC 中期预后评分

Bayoğlu, İbrahim Vedat; Hüseynov, Javid; Topal, Alper; Sever, Nadiye; Majidova, Nargiz; Çelebi, Abdussamet; Yaşar, Alper; Arıkan, Rukiye; Işık, Selver; Hacıoğlu, Muhammet Bekir; Ercelep, Özlem; Sarı, Murat; Erdoğan, Bülent; Hacıbekiroğlu, İlhan; Topaloğlu, Sernaz; Köstek, Osman; Çiçin, İrfan

Results of surgical treatment of pulmonary artery sarcomas: Does histology affect survival?

肺动脉肉瘤外科治疗结果:组织学类型是否影响生存率?

Başar, Veysel; Ermerak, N Onur; Olgun Yıldızeli, Şehnaz; Bozkurtlar, Emine; Ercelep, Özlem; Mutlu, Bülent; Kocakaya, Derya; Bekiroğlu, G Nural; Taş, Serpil; Yanartaş, Mehmed; Sunar, Hasan; Ak, Koray; Küçükoğlu, Serdar; Yıldızeli, Bedrettin

The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors

系统性免疫炎症指数与接受酪氨酸激酶抑制剂治疗的转移性肾细胞癌患者生存率之间的关系

Yücel, Kadriye Bir; Yekedüz, Emre; Karakaya, Serdar; Tural, Deniz; Ertürk, İsmail; Erol, Cihan; Ercelep, Özlem; Öztaş, Nihan Şentürk; Arslan, Çağatay; Uçar, Gökhan; Küçükarda, Ahmet; Sever, Özlem Nuray; Kılıçkap, Saadettin; Can, Orçun; Yazgan, Satı Coşkun; Öksüzoğlu, Berna; Karadurmuş, Nuri; Şendur, Mehmet Ali; Ürün, Yüksel

Prognostic Value of Tissue-Resident Memory T Cells and Tumor Microenvironmental Features in Resected Pancreatic Adenocarcinoma

组织驻留记忆T细胞和肿瘤微环境特征在切除的胰腺腺癌中的预后价值

Başoğlu, Tuğba; Akar, Kadriye Ebru; Bağcı, Pelin; Akgül Babacan, Nalan; Öztürk, Mehmet Akif; Öztürk, Fatih Emin; Demircan, Nazım Can; Arikan, Rukiye; Akın Telli, Tuğba; Ercelep, Özlem; Dane, Faysal; Yumuk, Perran Fulden

The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study

泛免疫炎症值与接受纳武利尤单抗二线及以上治疗的转移性肾细胞癌患者生存结局的关系:一项土耳其肿瘤协作组肾癌联盟(TKCC)研究

Yekedüz, Emre; Tural, Deniz; Ertürk, İsmail; Karakaya, Serdar; Erol, Cihan; Ercelep, Özlem; Arslan, Çağatay; Sever, Özlem Nuray; Kılıçkap, Saadettin; Şentürk Öztaş, Nihan; Küçükarda, Ahmet; Can, Orçun; Öksüzoğlu, Berna; Şendur, Mehmet Ali; Karadurmuş, Nuri; Ürün, Yüksel